A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of combined omacor [omega-3 ethylester concentrate] and simvastatin therapy in hypertriglyceridemic subjects
Latest Information Update: 17 Jul 2023
Price :
$35 *
At a glance
- Drugs Omega-3-acid ethyl esters (Primary) ; Simvastatin (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- Acronyms COMBOS
- Sponsors GlaxoSmithKline; GSK
- 15 Feb 2010 Results of the 2-year extension of this trial have been published in Current Medical Research and Opinion.
- 27 Nov 2005 New trial record.